Executive Summary
NextGen Group plc is a provider of expert systems, services and reagents focussed on enabling enhanced access to, and understanding of the role of, proteins in diagnosis and drug discovery. The expert systems are built out of NextGen's understanding of biological sciences and combines robotics, advanced engineering, rules based software in systems that range from partially to fully automated. NextGen Sciences also uses its systems and instruments to provide fee-for-service products to the pharmaceutical and biotechnology industry as well as to those in academic research. NextGen Sciences has developed a range of products several of which have already been successfully marketed to the biopharmaceutical industry including: OrchestratorIMSTM - an expert system which provides a link between biology, software and hardware. The ExpressionFactoryTM, the ExpressionWorkstationTM and the BaculoWorkstationTM - advanced robotics systems for high-throughput gene cloning and protein expression. The a2DE OptimizerTM - a proprietary instrument enabling the customisation of 2D electrophoresis gels, a major advance in protein analysis. In addition, NextGen has introduced a growing range of consumable reagents for use with the above products.
Company History
Current Events
Business Model
Products/Services
Segments/Customers
Production/Operations
Distribution/Routes to Market
Market & Competition
Market Share
Main Competitors
Competitive Strengths and Weaknesses
Management
Financials
Profit & Loss
Balance sheet
Cashflow
Valuation
Comparable Companies
SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
